SLF
ACOR

Sun Life Financial’s Acorda Therapeutics ACOR Stock Holding History

Sun Life Financial’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-215
Closed -$74K – 602
2019
Q3 		$74K Buy
215
+1
+0.5% +$544 0.02% 262
2019
Q2 		$197K Buy
214
+109
+104% +$134K 0.05% 181
2019
Q1 		$168K Hold
105
– – 0.04% 217
2018
Q4 		$196K Buy
105
+1
+1% +$2.18K 0.04% 199
2018
Q3 		$246K Buy
104
+35
+51% +$108K 0.04% 203
2018
Q2 		$237K Buy
+69
New +$211K 0.03% 198

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sun Life Financial's ACOR Position: Q4 2019 in Review

Sun Life Financial sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 215 shares — an estimated $74K sold.

Sun Life Financial first reported a position in ACOR in Q2 2018 and held it in 6 quarters. The position peaked at $246K in Q3 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Sun Life Financial reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Sun Life Financial sold 215 Acorda Therapeutics shares in Q4 2019, an estimated $74K.
  • Sun Life Financial first reported a position in Acorda Therapeutics in Q2 2018 and held it in 6 quarters.
  • Sun Life Financial's Acorda Therapeutics position peaked at $246K in Q3 2018.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Sun Life Financial's 13F filing for Q4 2019, filed 10 Feb 2020.